UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair

Clinical cancer research, 2020-04, Vol.26 (7), p.1690-1699

2020

Volltextzugriff (PDF)

Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model

Proceedings of the National Academy of Sciences - PNAS, 2013-07, Vol.110 (29), p.12006-12011

2013

Volltextzugriff (PDF)

The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA -Mutant Breast Cancer Brain Metastases

Clinical cancer research, 2019-06, Vol.25 (11), p.3374-3383

2019

Volltextzugriff (PDF)

Editorial: Recent advances in oncolytic virus therapy for brain tumors

Frontiers in cellular and infection microbiology, 2023-08, Vol.13, p.1271559-1271559

2023

Volltextzugriff (PDF)

Radiation-induced Extracellular Vesicle (EV) Release of miR-603 Promotes IGF1-mediated Stem Cell State in Glioblastomas

Neurosurgery, 2020-12, Vol.67 (Supplement_1)

2020

Volltextzugriff (PDF)

Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas

EBioMedicine, 2020-05, Vol.55, p.102736, Article 102736

2020

Volltextzugriff (PDF)

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma

Acta neuropathologica communications, 2020-12, Vol.8 (1), p.221-221, Article 221

2020

Volltextzugriff (PDF)

PI3K-gamma Inhibition Suppresses Accumulation of Glioblastoma-associated Microglia to Recapitulate the Microenvironment of Exceptional Responders

Neurosurgery, 2020-12, Vol.67 (Supplement_1)

2020

Volltextzugriff (PDF)

Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells

Molecular therapy. Oncolytics, 2019-06, Vol.13, p.58-66

2019

Volltextzugriff (PDF)

169 Off-the-shelf, engineered iPSC-derived NK cells mediate potent cytotoxic activity against primary glioblastoma cells and promote durable long-term survival in vivo

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A180-A180

2021

Volltextzugriff (PDF)

155 iPSC-derived NK cells mediate robust anti-tumor activity against glioblastoma

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A93-A94

2020

Volltextzugriff (PDF)

Therapeutic Application of PARP Inhibitors in Neuro-Oncology

Trends in Cancer, 2020-02, Vol.6 (2), p.147-159

2020

Volltextzugriff (PDF)

SURG-09. TARGETING A SHARED GLIOBLASTOMA CELL STATE THROUGH ADAPTIVE NATURAL KILLER CELLS AUGMENTED WITH TRISPECIFIC KILLER CELL ENGAGER (TRIKE) IMMUNE-MODULATOR AGAINST CD276

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v263-v263

2023

Volltextzugriff (PDF)

Combining oncolytic virus with FDA approved pharmacological agents for cancer therapy

Expert opinion on biological therapy, 2021-02, Vol.21 (2), p.183-189

2021

Volltextzugriff (PDF)

Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy

Frontiers in microbiology, 2014-06, Vol.5, p.303-303

2014

Volltextzugriff (PDF)

372 IPSC-Derived NK cells Exhibit Potent In Vitro and In Vivo Tumorcidal Activity Against Patient-Derived Glioblastoma Stem Cells (GSCs)

Neurosurgery, 2023-04, Vol.69 (Supplement_1), p.64-64

2023

Volltextzugriff (PDF)

Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma

JNCI : Journal of the National Cancer Institute, 2017-03, Vol.109 (3), p.1-13

2017

Volltextzugriff (PDF)

EXTH-64. IPSC-DERIVED NK CELLS EXHIBIT POTENT IN VITRO AND IN VIVO TUMORCIDAL ACTIVITY AGAINST PATIENT-DERIVED GLIOBLASTOMA STEM CELLS (GSCS)

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii224-vii224

2022

Volltextzugriff (PDF)

Restoration of Temozolomide Sensitivity by Poly(ADP-Ribose) Polymerase inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair

Clinical cancer research, 2020-01, Vol.26 (7), p.1690-1699

2020

Volltextzugriff (PDF)

PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response

Proceedings of the National Academy of Sciences - PNAS, 2021-04, Vol.118 (16), p.1

2021

Volltextzugriff (PDF)

Abstract 1122: ATR inhibitors synergize with PARP inhibitors in killing glioblastoma stem cells and treating glioblastoma

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1122-1122

2017

Volltextzugriff (PDF)

EPCO-19. INTEGRATED ANALYSIS OF INTRA-TUMORAL HETEROGENEITY IN GLIOBLASTOMAS THROUGH SINGLE NUCLEI ATAC-SEQ AND RNA-SEQ

Neuro-oncology (Charlottesville, Va.), 2020-11, Vol.22 (Supplement_2), p.ii73-ii73

2020

Volltextzugriff (PDF)

RBIO-04. LACTATE DEHYDROGENASE A (LDHA) MEDIATES NOVEL CROSSTALK BETWEEN METABOLIC GLYCOLYSIS AND CHROMATIN REMODELING

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Suppl 6), p.vi192-vi192

2021

Volltextzugriff (PDF)

RBIO-04. LACTATE DEHYDROGENASE A (LDHA) MEDIATES NOVEL CROSSTALK BETWEEN METABOLIC GLYCOLYSIS AND CHROMATIN REMODELING

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi192-vi192

2021

Volltextzugriff (PDF)

TAMI-58. TARGETING GLIOBLASTOMA BY ACTIVATING VIRAL SPECIFIC TISSUE-RESIDENT MEMORY T CELLS

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi210-vi210

2021

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(94)
Mit Volltextzugriff
(88)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Restoration of Temozolomide Sensitivity by PARP Inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair

Multifaceted oncolytic virus therapy for glioblastoma in an immunocompetent cancer stem cell model

The Dual PI3K/mTOR Pathway Inhibitor GDC-0084 Achieves Antitumor Activity in PIK3CA -Mutant Breast Cancer Brain Metastases

Editorial: Recent advances in oncolytic virus therapy for brain tumors

Radiation-induced Extracellular Vesicle (EV) Release of miR-603 Promotes IGF1-mediated Stem Cell State in Glioblastomas

Radiation-induced extracellular vesicle (EV) release of miR-603 promotes IGF1-mediated stem cell state in glioblastomas

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma

PI3K-gamma Inhibition Suppresses Accumulation of Glioblastoma-associated Microglia to Recapitulate the Microenvironment of Exceptional Responders

Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells

169 Off-the-shelf, engineered iPSC-derived NK cells mediate potent cytotoxic activity against primary glioblastoma cells and promote durable long-term survival in vivo

155 iPSC-derived NK cells mediate robust anti-tumor activity against glioblastoma

Therapeutic Application of PARP Inhibitors in Neuro-Oncology

SURG-09. TARGETING A SHARED GLIOBLASTOMA CELL STATE THROUGH ADAPTIVE NATURAL KILLER CELLS AUGMENTED WITH TRISPECIFIC KILLER CELL ENGAGER (TRIKE) IMMUNE-MODULATOR AGAINST CD276

Combining oncolytic virus with FDA approved pharmacological agents for cancer therapy

Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy

372 IPSC-Derived NK cells Exhibit Potent In Vitro and In Vivo Tumorcidal Activity Against Patient-Derived Glioblastoma Stem Cells (GSCs)

Rad51 Degradation: Role in Oncolytic Virus-Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy in Glioblastoma

EXTH-64. IPSC-DERIVED NK CELLS EXHIBIT POTENT IN VITRO AND IN VIVO TUMORCIDAL ACTIVITY AGAINST PATIENT-DERIVED GLIOBLASTOMA STEM CELLS (GSCS)

Restoration of Temozolomide Sensitivity by Poly(ADP-Ribose) Polymerase inhibitors in Mismatch Repair Deficient Glioblastoma is Independent of Base Excision Repair

PI3Kγ inhibition suppresses microglia/TAM accumulation in glioblastoma microenvironment to promote exceptional temozolomide response

Abstract 1122: ATR inhibitors synergize with PARP inhibitors in killing glioblastoma stem cells and treating glioblastoma

EPCO-19. INTEGRATED ANALYSIS OF INTRA-TUMORAL HETEROGENEITY IN GLIOBLASTOMAS THROUGH SINGLE NUCLEI ATAC-SEQ AND RNA-SEQ

RBIO-04. LACTATE DEHYDROGENASE A (LDHA) MEDIATES NOVEL CROSSTALK BETWEEN METABOLIC GLYCOLYSIS AND CHROMATIN REMODELING

RBIO-04. LACTATE DEHYDROGENASE A (LDHA) MEDIATES NOVEL CROSSTALK BETWEEN METABOLIC GLYCOLYSIS AND CHROMATIN REMODELING

TAMI-58. TARGETING GLIOBLASTOMA BY ACTIVATING VIRAL SPECIFIC TISSUE-RESIDENT MEMORY T CELLS

Suchergebnisse filtern